Skip Navigation

JNCI Journal of the National Cancer Institute 1997 89(22):1683-1691; doi:10.1093/jnci/89.22.1683
© 1997 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Potosky, A. L.
Right arrow Articles by Ballard- Barbash, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potosky, A. L.
Right arrow Articles by Ballard- Barbash, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal Of The National Cancer Institute, Vol 89, 1683-1691, Copyright © 1997 by Oxford University Press


ARTICLES

Breast cancer survival and treatment in health maintenance organization and fee-for-service settings

AL Potosky, RM Merrill, GF Riley, SH Taplin, W Barlow, BH Fireman and R Ballard- Barbash
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892-7344, USA. potosky@nih.gov

BACKGROUND: Enrollment in health maintenance organizations (HMOs) has increased rapidly during the past 10 years, reflecting a growing emphasis on health care cost containment. To determine whether there is a difference in the treatment and outcome for female patients with breast cancer enrolled in HMOs versus a fee-for-service setting, we compared the 10-year survival and initial treatment of patients with breast cancer enrolled in both types of plans. METHODS: With the use of tumor registries covering the greater San Francisco-Oakland and Seattle- Puget Sound areas, respectively, we obtained information on the treatment and outcome for 13,358 female patients with breast cancer, aged 65 years and older, diagnosed between 1985 and 1992. We linked registry information with Medicare data and data from the two large HMOs included in the study. We compared the survival and treatment differences between HMO and fee-for-service care after adjusting for tumor stage, comorbidity, and sociodemographic characteristics. RESULTS: In San Francisco-Oakland, the 10-year adjusted risk ratio for breast cancer deaths among HMO patients compared with fee-for-service patients was 0.71 (95% confidence interval [CI] = 0.59-0.87) and was comparable for all deaths. In Seattle-Puget Sound, the risk ratio for breast cancer deaths was 1.01 (95% CI = 0.77-1.33) but somewhat lower for all deaths. Women enrolled in HMOs were more likely to receive breast-conserving surgery than women in fee-for-service (odds ratio = 1.55 in San Francisco-Oakland; 3.39 in Seattle). HMO enrollees undergoing breast-conserving surgery were also more likely to receive adjuvant radiotherapy (San Francisco-Oakland odds ratio = 2.49; Seattle odds ratio = 4.62). CONCLUSIONS: Long-term survival outcomes in the two prepaid group practice HMOs in this study were at least equal to, and possibly better than, outcomes in the fee-for-service system. In addition, the use of recommended therapy for early stage breast cancer was more frequent in the two HMOs.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch DermatolHome page
S. M. Swetter, S. Soon, C. R. Harrington, and S. C. Chen
Effect of Health Care Delivery Models on Melanoma Thickness and Stage in a University-Based Referral Center: An Observational Pilot Study
Arch Dermatol, January 1, 2007; 143(1): 30 - 36.
[Abstract] [Full Text] [PDF]


Home page
J Aging HealthHome page
X. Xu and G. A. Jensen
Health Effects of Managed Care Among the Near-Elderly
J Aging Health, August 1, 2006; 18(4): 507 - 533.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. S. Kirsner, F. Ma, L. Fleming, D. G. Federman, E. Trapido, R. Duncan, and J. D. Wilkinson
The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 769 - 773.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. A. Buchholz, R. L. Theriault, J. C. Niland, M. E. Hughes, R. Ottesen, S. B. Edge, M. A. Bookman, and J. C. Weeks
The Use of Radiation As a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers
J. Clin. Oncol., January 20, 2006; 24(3): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
L. M. Woods, B. Rachet, and M. P. Coleman
Origins of socio-economic inequalities in cancer survival: a review
Ann. Onc., January 1, 2006; 17(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al.
Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment
J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. G. Elmore, L. M. Reisch, M. B. Barton, W. E. Barlow, S. Rolnick, E. L. Harris, L. J. Herrinton, A. M. Geiger, R. K. Beverly, G. Hart, et al.
Efficacy of Breast Cancer Screening in the Community According to Risk Level
J Natl Cancer Inst, July 20, 2005; 97(14): 1035 - 1043.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. J. Herrinton, W. E. Barlow, O. Yu, A. M. Geiger, J. G. Elmore, M. B. Barton, E. L. Harris, S. Rolnick, R. Pardee, G. Husson, et al.
Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network Project
J. Clin. Oncol., July 1, 2005; 23(19): 4275 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
A. Stark, G. Kucera, M. Lu, S. Claud, and J. Griggs
Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of breast cancer patients
Int. J. Qual. Health Care, December 1, 2004; 16(6): 517 - 521.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Mandelblatt, C. B. Schechter, K. R. Yabroff, W. Lawrence, J. Dignam, P. Muennig, Y. Chavez, J. Cullen, and M. Fahs
Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women
J. Clin. Oncol., July 1, 2004; 22(13): 2554 - 2566.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
T. Morrow, M. Siegel, S. Boone, G. Lawless, and W. Carter
Chemotherapy Dose Intensity Determination as a Quality of Care Measure for Managed Care Organizations in the Treatment of Early-Stage Breast Cancer
American Journal of Medical Quality, November 1, 2002; 17(6): 218 - 224.
[Abstract] [PDF]


Home page
JCOHome page
M. L. Pearson, P. A. Ganz, K. McGuigan, J. R. Malin, J. Adams, and K. L. Kahn
The Case Identification Challenge in Measuring Quality of Cancer Care
J. Clin. Oncol., November 1, 2002; 20(21): 4353 - 4360.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Malin, M. A. Schuster, K. A. Kahn, and R. H. Brook
Quality of Breast Cancer Care: What Do We Know?
J. Clin. Oncol., November 1, 2002; 20(21): 4381 - 4393.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
R. H. Miller and H. S. Luft
HMO Plan Performance Update: An Analysis Of The Literature, 1997-2001
Health Aff., July 1, 2002; 21(4): 63 - 86.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. L. Malin, K. L. Kahn, J. Adams, L. Kwan, M. Laouri, and P. A. Ganz
Validity of Cancer Registry Data for Measuring the Quality of Breast Cancer Care
J Natl Cancer Inst, June 5, 2002; 94(11): 835 - 844.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. L. Warren, M. L. Brown, M. P. Fay, N. Schussler, A. L. Potosky, and G. F. Riley
Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings
J. Clin. Oncol., January 1, 2002; 20(1): 307 - 316.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. H. Fireman, L. Fehrenbacher, E. P. Gruskin, and G. T. Ray
Cost of Care for Patients in Cancer Clinical Trials
J Natl Cancer Inst, January 19, 2000; 92(2): 136 - 142.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. G. Roetzheim, N. Pal, C. Tennant, L. Voti, J. Z. Ayanian, A. Schwabe, and J. P. Krischer
Effects of Health Insurance and Race on Early Detection of Cancer
J Natl Cancer Inst, August 18, 1999; 91(16): 1409 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Med Care Res RevHome page
R. M. Merrill, M. L. Brown, A. L. Potosky, G. Riley, S. H. Taplin, W. Barlow, and B. H. Fireman
Survival and Treatment for Colorectal Cancer Medicare Patients in Two Group/Staff Health Maintenance Organizations and the Fee-for-Service Setting
Med Care Res Rev, June 1, 1999; 56(2): 177 - 196.
[Abstract] [PDF]


Home page
JAMAHome page
G. F. Riley, A. L. Potosky, C. N. Klabunde, J. L. Warren, and R. Ballard-Barbash
Stage at Diagnosis and Treatment Patterns Among Older Women With Breast Cancer: An HMO and Fee-for-Service Comparison
JAMA, February 24, 1999; 281(8): 720 - 726.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. E. Hillner and T. J. Smith
Hospital Volume and Patient Outcomes in Major Cancer Surgery: A Catalyst for Quality Assessment and Concentration of Cancer Services
JAMA, November 25, 1998; 280(20): 1783 - 1785.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.